Serum prolactin levels following augmentation mammaplasty.
A prospective study to evaluate the possible relationship between augmentation mammaplasty, a chronic irritant to the breast, and serum prolactin levels was carried out. Eleven healthy female subjects were studied. Serum prolactin levels were determined twice prior to surgery and at 1 and 3 weeks after surgery. No significant change was detected in the postoperative prolactin values. In four subjects evaluated 3 months following surgery, the prolactin levels also remained unchanged. In addition, none of the women developed galactorrhea during their observation period. These results suggest that the placement of a Silastic implant for augmentation mammaplasty may not be a chronic stimulus leading to either galactorrhea or elevation of prolactin levels.
D000328:Adult; D001940:Breast / Q000601:surgery*; D005260:Female; D006801:Humans; D011183:Postoperative Complications; D011388:Prolactin / Q000097:blood*; D011446:Prospective Studies; D019736:Prostheses and Implants / Q000009:adverse effects*; D013518:Surgery, Plastic / Q000009:adverse effects
D011388:Prolactin